06Mar
CFIUS Proposes Filing Fees for Transaction Reviews
The U.S. Department of the Treasury late yesterday released a draft set of regulations that would establish, for the first time, filing fees for most transactions submitted to the Committee on Foreign Investment in the United States (CFIUS). Under...
By:
Shearman & Sterling LLP
Related
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 bi...
Read More >
One of the critical elements found in the 2019 Guidance is the need to use the information you obtai...
Read More >
Numerous reports have documented the softening condominium market in New York and other large cities...
Read More >
The Italian pharmaceutical company Angelini Pharma announced on January 4, 2021, that it will acquir...
Read More >
On June 29, 2020, the Japan Fair Trade Commission (“JFTC”) issued a draft of amendments to relevan...
Read More >
The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for ph...
Read More >